Trials / Conditions / Pathologic Stage IV Esophageal Adenocarcinoma AJCC v8

Pathologic Stage IV Esophageal Adenocarcinoma AJCC v8

6 registered clinical trials studyying Pathologic Stage IV Esophageal Adenocarcinoma AJCC v8.

Status	Trial	Sponsor	Phase
Active Not Recruiting	Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events NCT05038254	M.D. Anderson Cancer Center	N/A
Active Not Recruiting	Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Eso NCT04460937	National Cancer Institute (NCI)	Phase 1
Active Not Recruiting	Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Ga NCT04248452	ECOG-ACRIN Cancer Research Group	Phase 3
Completed	Real-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS Study NCT04449679	Thomas Jefferson University	N/A
Completed	Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes NCT04501913	City of Hope Medical Center	—
Completed	Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal Adenocarcinoma NCT03395847	M.D. Anderson Cancer Center	EARLY_Phase 1